Cancer Cell study: Blood Platelets offer all-in-one cancer diagnostics platform

Amsterdam, 29th October 2015: thromboDx, a molecular diagnostics company based in Amsterdam, the Netherlands announced that a 283 subject study shows that its’ blood platelets based diagnostic platform enables accurate detection, classification and subtyping of cancer in the equivalent of one drop of blood. The study was published today in Cancer Cell and suggests that…


thromboDx acquires prestigious EUROSTARS grant

Amsterdam, The Netherlands – thromboDx, the molecular diagnostics company that develops and commercializes blood-based diagnostics through its proprietary platelet-powered technology platform, announces that is has received a prestigious EUROSTARS grant.


Follow @thromboDx on TWITTER

thromboDx can now also be found on Twitter. We will be posting our press releases and interesting news items there. Follow us @thromboDx